Houston, Texas, April 13, 2022 (GLOBE NEWSWIRE) — PCCA, a Houston-based, FDA-registered provider of active pharmaceutical ingredients, excipients, and technical guidance for pharmacies, healthcare facilities and outsourced installations, is pleased to announce a strategic partnership agreement with KUNESA, the world leader in design and integrated luminaires for pharmacies, laboratories and front-end. This partnership brings together leaders in pharmaceutical compounding and advanced pharmaceutical design, enabling PCCA members to save on design and construction costs while improving operational efficiency.
The US Pharmacopeia Convention (USP) updated USP General Chapter 800 on December 1, 2019 to establish standards for the safe handling of hazardous drugs to minimize the risk of exposure to healthcare personnel, patients, and physicians. ‘environment. The specifications outlined in this chapter are causing many pharmacies across the United States to redesign their facilities.
“KUNESA truly understands the ins and outs of non-sterile, hazardous and non-hazardous drug compounding, so our member pharmacies can rest assured that their facility is compliant with USP 800 specifications,” said Menia Costopoulos, Vice President of PCCA’s sales and marketing. “We are delighted to offer our members the opportunity to access KUNESA’s stylish design options at preferential prices when renovating or upgrading their work environments.”
KUNESA offers customized space-saving design solutions for entire pharmacy operations including prescription filling area, front and durable medical equipment area, compounding lab, wellness center , medical spa and more. After availing his services, most KUNESA customers are able to significantly increase their sales of prescription products as well as high-margin frontal products, such as skincare, cosmeceuticals and nutritional supplements. , by more than 100% during the first few months. Additionally, they are able to increase the ratio of initial sales to prescription sales from the usual 1-3% to over 15%.
Other benefits of working with KUNESA:
Compact medication storage systems reduce the footprint area of the pharmacy by approximately 50%, allowing for much more efficient operation. All lab materials and surfaces exceed USP 800 specifications. The unique design allows pharmacies to partner with higher margin OTC brands to become the healthcare and wellness destination of choice for customers. Custom electrical, ceiling, lighting and floor plans are included at no additional cost. Planning services include architectural 3D renderings and a 360 degree 3D guided tour.
“Our specialists look forward to helping PCCA member compounding pharmacies differentiate themselves from their competitors and secure their position as the premier healthcare and wellness destination by dramatically increasing the attractiveness and efficiency in all areas of their operation,” said Johannes M. Heine, Managing Partner of KUNESA LLC. , MBA.
PCCA members can learn more about working with KUNESA at bit.ly/pcca-kunesa.
KUNESA is the world leader in pharmacy design. Over the past 50 years, KUNESA has helped more than 8,000 independent pharmacies in more than 35 countries, including more than 50 compounding pharmacies in the United States, to become even more successful. Learn more and check out design solutions at bit.ly/kunesa-pharmacy.
PCCA supports the creation of personalized medicine and innovative products that make a difference in the lives of patients. As a comprehensive resource for independent pharmacies and healthcare systems, PCCA provides high-quality products, training and support to more than 3,000 member pharmacies in the United States, Canada, Australia and other country of the world. Incorporated in 1981 by a network of pharmacists, PCCA has been supporting pharmaceutical preparation for over 40 years. Learn more at pccarx.com.
The partnership between PCCA and KUNESA brings together leaders in pharmaceutical preparation and advanced pharmaceutical design.
Kim Speairs, APR, MBA PCCA 832.295.4225 [email protected]
Copyright 2022 GlobeNewswire, Inc.